Authors: MATUSZEWSKA B HETTRICK L BONDI JV STOREY DE

Citation: B. Matuszewska et al., COMPARATIVE BIOAVAILABILITY OF L-683,453, A 5-ALPHA-REDUCTASE INHIBITOR, FROM A SELF-EMULSIFYING DRUG-DELIVERY SYSTEM IN BEAGLE DOGS, International journal of pharmaceutics, 136(1-2), 1996, pp. 147-154

Authors: BIENIECKI A MATUSZEWSKA B WILK KA

Citation: A. Bieniecki et al., NUCLEOPHILIC AROMATIC-SUBSTITUTION IN MICROEMULSIONS STABILIZED BY CHEMODEGRADABLE SURFACTANTS, Polish Journal of Chemistry, 69(8), 1995, pp. 1174-1181

Authors: RHODES L PRIMKA R BERMAN C GATO G AUDETTEARRUDA J PIKOUNIS B MATUSZEWSKA B HARPER J

Citation: L. Rhodes et al., EFFECTS OF 1-YEAR TREATMENT WITH ORAL MK386, AN INHIBITOR OF TYPE-1 5-ALPHA-REDUCTASE, IN THE STUMPTAILED MACAQUE (MACACA-ARCTOIDES), Journal of investigative dermatology, 104(4), 1995, pp. 658-658

Authors: WILK KA BIENIECKI A MATUSZEWSKA B

Citation: Ka. Wilk et al., EFFECT OF CYCLIC ACETAL-TYPE CATIONIC SURFACTANTS ON THE BASIC DEHYDROBROMINATION REACTION, Journal of physical organic chemistry, 7(11), 1994, pp. 646-651

Authors: MATUSZEWSKA B KEOGAN M FISHER DM SOPER KA HOE CM HUBER AC BONDI JV

Citation: B. Matuszewska et al., ACIDIC FIBROBLAST GROWTH-FACTOR - EVALUATION OF TOPICAL FORMULATIONS IN A DIABETIC MOUSE WOUND-HEALING MODEL, Pharmaceutical research, 11(1), 1994, pp. 65-71

Authors: TSAI PK VOLKIN DB DABORA JM THOMPSON KC BRUNER MW GRESS JO MATUSZEWSKA B KEOGAN M BONDI JV MIDDAUGH CR

Citation: Pk. Tsai et al., FORMULATION DESIGN OF ACIDIC FIBROBLAST GROWTH-FACTOR, Pharmaceutical research, 10(5), 1993, pp. 649-659